We confirmed that MYLK2 was highly expressed in PRAD by qPCR of normal prostate epithelial cell line RWPE-1 as well as prostate cancer cell lines PC-3 and LNCaP clone FGC, and Western blotting (WB). Here, MYLK2 is linked to prostate carcinoma.